Tracked deals
58
58 tracked deals across 2015-2026.
New York, New York, United States
Arsenal is a private equity firm specializing in investments in middle-market industrial growth and healthcare companies, working with management teams to build strategically important, market-leading businesses.
Tracked deals
58
58 tracked deals across 2015-2026.
Recent pace
3
3 tracked deals announced in the last 12 months.
Deal mix
Addon
34 addon · 19 buyout · 2 growth capital
Last 9 years
Supporting Data
Showing the 12 most recent of 58 tracked deals for Arsenal Capital Partners.
Arsenal Capital Partners has agreed to acquire a majority stake in Velcro Companies from the Cripps Foundation. Arsenal will become the majority owner, while the Cripps Foundation will retain a significant minority stake; financial terms were not disclosed and the deal is expected to close in Q4 2026 subject to regulatory approvals.
Arsenal Capital Partners completed its acquisition of ThermoSafe, a temperature-assurance packaging business, from Sonoco Products Company. The deal was originally announced as a signed definitive agreement in September 2025 with a total purchase price of up to $725 million, including performance-based additional consideration.
Polycorp, a portfolio company of Arsenal Capital Partners, has acquired Burke Industries Inc. from Mannington Mills. The deal expands Polycorp's manufacturing footprint and technical capabilities in engineered elastomeric solutions, while Mannington will continue to manufacture Burke rubber flooring products at its Florida and Georgia facilities.
Knowtion Health, a Boca Raton-based, PE-backed revenue cycle management provider, has completed the acquisition of Switch RCM, a data- and technology-first healthcare revenue intelligence firm based in Madison. The deal expands Knowtion’s automation, analytics and recovery capabilities and brings multiple Switch leaders into Knowtion’s executive and innovation teams; terms were not disclosed.
Headwall Group, a Bolton, Massachusetts-based portfolio company of Arsenal Capital Partners, has acquired Austria-based EVK DI Kerschhaggl GmbH (EVK), a developer of industrial sensor-based sorting and inspection systems. The acquisition expands Headwall's hyperspectral imaging and sensor capabilities to better serve markets such as food processing, plastics recycling, and material sorting.
Arsenal Capital Partners has signed a definitive agreement to acquire Knowtion Health, a provider of AI-enabled revenue cycle and insurance claim resolution services. Sunstone Partners, the current majority owner, will remain a strategic co-investor; financial terms were not disclosed.
An investor group led by Arsenal Capital Partners, in partnership with BayPine LP, has acquired Poly-Wood, LLC (POLYWOOD) from Mayfair Capital Partners (a division of Oxford Financial Group). POLYWOOD is a vertically integrated manufacturer of recycled HDPE outdoor living products headquartered in Syracuse, Indiana, employing about 1,650 people; Arsenal and BayPine plan to invest in organic and inorganic growth and further develop the company's digital capabilities.
Arsenal Capital Partners has acquired Fortrea's Endpoint Clinical and Fortrea Patient Access businesses in a divestiture completed June 4, 2024. The sale allows Fortrea to sharpen its focus as a pure‑play CRO while Arsenal will position Endpoint and the Patient Access business for accelerated investment and growth under management led by Sam Osman.
Arsenal Capital Partners completed a majority investment in Polycorp Ltd., a Canadian manufacturer of engineered elastomer solutions. Terms were not disclosed; Polycorp (headquartered in Elora, Ontario) employs ~250 people and founder Peter Snucins will remain an investor and board member as the company pursues manufacturing, R&D and strategic growth initiatives.
Headwall Photonics, a Bolton, Massachusetts-based portfolio company of Arsenal Capital Partners, has acquired inno-spec GmbH of Nuremberg, Germany. The add-on expands Headwall's industrial hyperspectral imaging capabilities for high-volume recycling, industrial sorting and quality-testing applications and aims to integrate inno-spec's industrial solutions with Headwall's optical components and remote-sensing technologies.
Arsenal Capital Partners closed a previously announced $449 million stock purchase in Certara, acquiring shares from funds controlled by EQT Private Equity and becoming a long-term minority investor. As part of the transaction Arsenal appointed Operating Partner David Spaight to Certara's board while Stephen McLean remains a director; Arsenal agreed to a two-year lock-up on the newly purchased shares.
Lumanity, a portfolio company of Arsenal Capital Partners, has acquired Boston-based life sciences consultancy Clarion Healthcare from Svoboda Capital Partners. The undisclosed transaction expands Lumanity’s U.S. commercialization and product lifecycle consulting capabilities and creates greater global scale for life sciences strategy services.
Turn tracked acquisition activity into an outreach-ready buyer list.